EC 35 (Atelvia risedronate sodium delayed-release 35 mg)

Generic Name: risedronate

Pill with imprint EC 35 is Yellow, Capsule-shape and has been identified as Atelvia risedronate sodium delayed-release 35 mg. It is supplied by Allergan, Inc..

Atelvia is used in the treatment of osteoporosis and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy. Atelvia risedronate sodium delayed-release 35 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for EC 35

Atelvia

Generic Name:

risedronate

Imprint:

EC 35

Strength:

risedronate sodium delayed-release 35 mg

Color:

Yellow

Size:

12.00 mm

Shape:

Capsule-shape

Availability:

Prescription only

Drug Class:

Bisphosphonates

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Labeler / Supplier:

Allergan, Inc.

Inactive Ingredients:

• edetate disodium
• ferric oxide yellow
• magnesium stearate
• methacrylic acid - ethyl acrylate copolymer (1:1) type a
• polysorbate 80
• microcrystalline cellulose
• silicon dioxide
• sodium starch glycolate type A potato
• stearic acid
• magnesium silicate
• triethyl citrate

Note: Inactive ingredients may vary.

Labelers / Repackagers:

NDC Code	Labeler / Repackager
00430-0979	Warner Chilcott
00591-3876	Watson Pharmaceuticals, Inc.

More Info Imprint Search Print

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer